Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07257718
What this trial is testing

The Combined Role of FAPI PET and Liquid Biopsy in the Staging and Clinical Management of Bladder Cancer - FUTURE Trial

Who this might be right for
Bladder Cancer
Chiti Arturo 262
Large-scale testing (Phase 3)UnknownNCT03779035
What this trial is testing

Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection

Who this might be right for
CholangiocarcinomaGall Bladder Carcinoma
Tianjin Medical University Cancer Institute and Hospital 460
Testing effectiveness (Phase 2)Study completedNCT00055835
What this trial is testing

S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium

Who this might be right for
Bladder CancerUrethral Cancer
SWOG Cancer Research Network 7
Not applicableUnknownNCT04391790
What this trial is testing

MOdified Urinary Conduit to Lower Strictures After radIcal Cystectomy

Who this might be right for
Bladder Cancer
Jørgen Bjerggaard Jensen 300
Not applicableNot Yet RecruitingNCT07285408
What this trial is testing

Sarcopenia and NMIBC Prognosis Study

Who this might be right for
Bladder Cancer Cell Transitional
General Hospital Sveti Duh 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT03179943
What this trial is testing

Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Fox Chase Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT01328574
What this trial is testing

TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaUreteral NeoplasmsUreter Cancer+2 more
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT02387996
What this trial is testing

Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 270
Not applicableStudy completedNCT02080650
What this trial is testing

Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)

Who this might be right for
Prostate CancerRenal Cell CarcinomaBladder Cancer+5 more
Duke University 62
Early research (Phase 1)UnknownNCT05829057
What this trial is testing

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

Who this might be right for
Esophagus CancerBladder CancerLiver Cancer+2 more
Zhejiang University 10
Not applicableNot Yet RecruitingNCT07125924
What this trial is testing

Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer

Who this might be right for
Bladder CancerRadiation Cystitis
National Cancer Center, Korea 54
Testing effectiveness (Phase 2)Study completedNCT03674424
What this trial is testing

Avelumab as Neoadjuvant Therapy in Subjects With Urothelial Muscle Invasive Bladder Cancers (AURA Trial)

Who this might be right for
Non-metastatic Muscle Invasive Bladder Cancer
Jules Bordet Institute 137
Early research (Phase 1)Looking for participantsNCT05614739
What this trial is testing

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Who this might be right for
Urinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms
Eli Lilly and Company 677
Testing effectiveness (Phase 2)Study completedNCT04496219
What this trial is testing

Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Urothelial Carcinoma In SituRecurrent Bladder Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8+3 more
Fred Hutchinson Cancer Center 45
Testing effectiveness (Phase 2)Ended earlyNCT01234519
What this trial is testing

A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy

Who this might be right for
Urothelial Carcinoma
AEterna Zentaris 12
Not applicableUnknownNCT06115434
What this trial is testing

Comparing Operative, Postoperative and Quality of Life of Patients After Salvage and Radical Cystectomy

Who this might be right for
Urinary Bladder Cancer
Assiut University 80
Not applicableActive Not RecruitingNCT07391137
What this trial is testing

CRUCIAL-R Study : Cruciferous Vegetables Dietary Regimen in NMIBC

Who this might be right for
Recurrence Free SurvivalBladder Cancer Recurrence
S. Andrea Hospital 250
Not applicableStudy completedNCT04994639
What this trial is testing

Hypotension Prediction Effect on AKI

Who this might be right for
Bladder Cancer
Ewha Womans University Mokdong Hospital 120
Not applicableStudy completedNCT05033067
What this trial is testing

The Personal Patient Profile Decision Support for Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
Icahn School of Medicine at Mount Sinai 24
Testing effectiveness (Phase 2)Study completedNCT04553939
What this trial is testing

Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer

Who this might be right for
Urothelial CarcinomaBladder Cancer
Henan Cancer Hospital 50
Next Page